Follow

Submissions from 2014

Link

APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms, C. Conejero-Goldberg, J. J. Gomar, T. Bobes-Bascaran, T. M. Hyde, J. E. Kleinman, M. M. Herman, S. Chen, P. Davies, and T. Goldberg

PDF

Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode, C. U. Correll, M. Hauser, J. B. Penzner, A. M. Auther, V. Kafantaris, E. Saito, D. Olvet, R. E. Carrion, M. Pavuluri, B. A. Cornblatt, and +4 additional authors

PDF

The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls, C. U. Correll, D. M. Olvet, A. M. Auther, M. Hauser, T. Kishimoto, R. Carrion, S. Snyder, and B. A. Cornblatt

Link

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study, C. U. Correll, D. G. Robinson, N. R. Schooler, M. F. Brunette, K. T. Mueser, R. A. Rosenheck, P. Marcy, J. Severe, R. Heinssen, J. M. Kane, and +6 additional authors

Link

Safety profile of iloperidone in the treatment of schizophrenia, N. V. Dargani and A. K. Malhotra

PDF

Adding insult to injury: Childhood and adolescent risk factors for psychosis predict lower fractional anisotropy in the superior longitudinal fasciculus in healthy adults, P. DeRosse, T. Ikuta, B. D. Peters, K. Karlsgodt, P. Szeszko, and A. K. Malhotra

PDF

The relation between childhood maltreatment and psychosis in patients with schizophrenia and non-psychiatric controls, P. DeRosse, G. C. Nitzburg, B. Kompancaril, and A. K. Malhotra

PDF

Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study, J. K. Forsyth, C. E. Bearden, J. Addington, B. Goodyear, K. S. Cadenhead, H. Mirzakhanian, B. A. Cornblatt, D. M. Olvet, M. L. Qiu, T. D. Cannon, and +13 additional authors

PDF

Disease variants in genomes of 44 centenarians, Y. Freudenberg-Hua, J. Freudenberg, D. Oschwald, E. Christen, J. Koppel, B. Greenwald, R. B. Darnell, S. Germer, G. Atzmon, P. Davies, and +5 additional authors

Link

Olanzapine for the Treatment of Psychiatric Illness and Urticaria: A Case Report, Y. J. Girshman, Y. Wang, and A. J. Mendelowitz

PDF

APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain, J. J. Gomar, M. L. Gordon, P. B. Kingsley, A. M. Ulug, L. Keehlisen, S. Huet, J. J. Buthorn, J. Koppel, E. Christen, C. Conejero-Goldberg, P. Davies, T. E. Goldberg, and +1 additional author

Link

Reply to: The Impact of Magnetic Resonance Spectroscopy in Elucidating the Role of Apolipoprotein E Epsilon4 in Preclinical Alzheimer's Disease, J. J. Gomar, P. B. Kingsley, A. M. Ulug, C. Conejero-Goldberg, P. Barker, and T. E. Goldberg

PDF

Independent Component Analysis of Resting State Activity in Pediatric Obsessive-Compulsive Disorder, P. Gruner, A. Vo, M. Argyelan, T. Ikuta, A. J. Degnan, M. John, B. D. Peters, A. K. Malhotra, A. M. Ulug, and P. Szeszko

Link

Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy, T. Hirota, S. Schwartz, and C. U. Correll

PDF

A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure, T. Ikuta, B. D. Peters, S. Guha, M. John, K. H. Karlsgodt, T. Lencz, P. R. Szeszko, and A. K. Malhotra

PDF

Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis, T. Ikuta, D. G. Robinson, J. A. Gallego, B. D. Peters, P. Gruner, J. M. Kane, M. John, S. Sevy, A. K. Malhotra, and P. R. Szeszko

PDF

Abnormal cingulum bundle development in autism: A probabilistic tractography study, T. Ikuta, K. M. Shafritz, J. Bregman, B. D. Peters, P. Gruner, A. K. Malhotra, and P. R. Szeszko

Link

Mitochondrial DNA Mutations and Cognition: A Case-Series Report, G. Inczedy-Farkas, J. W. Trampush, D. P. Forintos, D. Beech, M. Andrejkovics, Z. Varga, V. Remenyi, B. Bereznai, A. Gal, and M. J. Molnar

Link

The significance of an isolated elevated TSH level in a depressed patient: a clinical commentary, R. T. Joffe and T. B. Sullivan

PDF

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials, Taishiro Kishimoto, A. Robenzadeh, C. Leucht, S. Leucht, K. Watanabe, M. Mimura, M. Borenstein, John Kane, and Christoph Correll

PDF

Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities, Jeremy Koppel, C. Acker, P. Davies, O. L. Lopez, H. Jimenez, M. Azose, Blaine Greenwald, P. S. Murray, C. M. Kirkwood, J. Kofler, and R. A. Sweet

Link

Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease, Jeremy Koppel, H. Jimenez, M. Azose, C. D'Abramo, C. Acker, J. Buthorn, Blaine Greenwald, J. Lewis, M. Lesser, Z. Liu, and P. Davies

Link

Psychosis in Alzheimer's Disease is Associated with Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings from the Alzheimer's Disease Neuroimaging Initiative, Jeremy Koppel, S. Sunday, Terry Goldberg, P. Davies, E. Christen, Blaine Greenwald, and Initi Alzheimer's Dis Neuroimaging

PDF

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease, Jeremy Koppel, V. Vingtdeux, P. Marambaud, C. d'Abramo, H. Jimenez, M. Stauber, R. Friedman, and P. Davies

PDF

Positive and negative subclinical symptoms and MCCB performance in non-psychiatric controls, C. Korponay, G. C. Nitzburg, Anil Malhotra, and P. DeRosse

Link

Emerging drugs for schizophrenia: an update, L. S. Koster, M. Carbon, and Christoph Correll

PDF

The influence of neighborhood characteristics on police officers' encounters with persons suspected to have a serious mental illness, S. Krishan, R. Bakeman, B. Broussard, S. L. Cristofaro, D. Hankerson-Dyson, L. Husbands, A. C. Watson, and Michael Compton

PDF

alpha 7 Nicotinic Acetylcholine Receptor Signaling Inhibits Inflammasome Activation by Preventing Mitochondrial DNA Release, B. Lu, K. Kwan, Y. A. Levine, P. S. Olofsson, H. Yang, J. H. Li, S. Joshi, H. C. Wang, U. Andersson, S. S. Chavan, and K. J. Tracey

Link

Acanthosis Nigricans During Treatment With Aripiprazole, P. Manu, Z. Al-Dhaher, N. Dargani, and C. U. Correll

Link

Elevated Blood Urea Nitrogen and Medical Outcome of Psychiatric Inpatients, P. Manu, Z. Al-Dhaher, S. Khan, J. M. Kane, and C. U. Correll

Link

Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects, P. Manu, C. U. Correll, M. Wampers, R. van Winkel, W. Yu, D. Shiffeldrim, and M. De Hert

Link

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission, P. Manu, S. Khan, R. Radhakrishnan, M. J. Russ, J. M. Kane, and C. U. Correll

PDF

Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial, D. J. Miklowitz, M. P. O'Brien, D. A. Schlosser, J. Addington, K. A. Candan, B. C. Walsh, J. L. Zinberg, S. D. De Silva, M. Friedman-Yakoobian, T. D. Cannon, and +2 additional authors

PDF

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report, I. Miura, S. Kono, S. Oshima, K. Kanno-Nozaki, H. Mashiko, S. I. Niwa, and H. Yabe

Link

Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia, I. Miura, T. Shiga, A. Katsumi, K. Kanno-Nozaki, H. Mashiko, S. I. Niwa, and H. Yabe

PDF

BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis, I. Miura, Jianping Zhang, M. Nitta, T. Lencz, John Kane, Anil Malhotra, H. Yabe, and Christoph Correll

PDF

Excess of homozygosity in the major histocompatibility complex in schizophrenia, S. Mukherjee, S. Guha, M. Ikeda, N. Iwata, Anil Malhotra, I. Pe'er, A. Darvasi, and T. Lencz

Clinical Correlates of Initial Treatment Disengagement in First-Episode Psychosis, N. Myers, S. Bhatty, B. Broussard, and Michael Compton

Link

This issue: Frontiers in Placebo Effects, D. Nayak

PDF

MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults, G. C. Nitzburg, P. DeRosse, K. E. Burdick, B. D. Peters, C. B. Gopin, and Anil Malhotra

PDF

A Randomized Trial of Family Focused Therapy With Populations at Clinical High Risk for Psychosis: Effects on Interactional Behavior, M. P. O'Brien, D. J. Miklowitz, K. A. Candan, C. Marshall, I. Domingues, B. C. Walsh, J. L. Zinberg, S. D. De Silva, K. A. Woodberry, and T. D. Cannon

PDF

Age-Related Differences in White Matter Tract Microstructure Are Associated with Cognitive Performance from Childhood to Adulthood, B. D. Peters, T. Ikuta, P. DeRosse, M. John, K. E. Burdick, P. Gruner, D. M. Prendergast, Philip Szeszko, and Anil Malhotra

PDF

Brain White Matter Development Is Associated with a Human-Specific Haplotype Increasing the Synthesis of Long Chain Fatty Acids, B. D. Peters, A. N. Voineskos, P. R. Szeszko, T. A. Lett, P. DeRosse, S. Guha, K. H. Karlsgodt, M. John, T. Lencz, A. K. Malhotra, and +4 additional authors

THE MODIFYING EFFECT A PMP22 DELETION IN A FAMILY WITH CHARCOT-MARIE-TOOTH TYPE 1 NEUROPATHY DUE TO AN EGR2 MUTATION, V. Remenyi, G. Inczedy-Farkas, A. Gal, B. Bereznai, Z. Pal, V. Karcagi, F. Mechler, and M. J. Molnar

PDF

Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla, K. Rhindress, T. Ikuta, R. Wellington, A. K. Malhotra, and P. Szeszko

Link

Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression, S. Schwartz and C. U. Correll

PDF

Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach, M. Shulman, A. Miller, J. Misher, and A. Tentler

Link

Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals, E. Soda, I. Miura, H. Hoshino, K. Kanno-Nozaki, T. Ota, H. Oguchi, K. Watanabe, Q. H. Yang, H. Mashiko, and S. I. Niwa

PDF

White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis, P. Szeszko, D. G. Robinson, T. Ikuta, B. D. Peters, J. Gallego, J. Kane, and A. K. Malhotra

PDF

Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment*, N. Toteja, J. Gallego, E. Saito, T. Gerhard, A. Winterstein, M. Olfson, and C. U. Correll

PDF

Age-associated alterations in corpus callosum white matter integrity in bipolar disorder assessed using probabilistic tractography, N. Toteja, P. Guvenek-Cokol, T. Ikuta, V. Kafantaris, B. D. Peters, K. E. Burdick, M. John, A. K. Malhotra, and P. Szeszko

PDF

Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes, V. Vacic, L. J. Ozelius, L. N. Clark, A. Bar-Shira, M. Gana-Weisz, T. Gurevich, A. Gusev, S. Guha, T. Lencz, A. Orr-Urtreger, and +10 additional authors

PDF

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs, R. Yoshimura, T. Kishi, H. Hori, A. Katsuki, A. Sugita-Ikenouchi, W. Umene-Nakano, K. Atake, N. Iwata, and J. Nakamura